Skip to content
The Great News – Lifestyle
Home
Sample Page
Author:
Adneuris Therapeutics, Inc.
Adneuris Therapeutics to Present at PAINWeek 2026
September 3, 2026
Adneuris Therapeutics Grants Exclusive License to Maruishi Pharmaceutical to Advance Cebranopadol in Japan and South Korea
August 5, 2026
Adneuris Therapeutics Grants Exclusive License to Zhejiang Conba Pharmaceutical to Advance Cebranopadol in Greater China
July 14, 2026
Tris Pharma Launches Adneuris Therapeutics to Advance a New Era in Pain Medicine
July 9, 2026